"Intelligence coup" for drug designers: Crystal structure of Staphylococcus aureus β-lactam resistance protein PBP2A

Lancet

Volumn 361, Issue 9360, 2003, Pages 795-796

  Tomasz, Alexander ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM DERIVATIVE; METICILLIN; NITROCEFIN; PENICILLIN G; PENICILLINASE; SERINE;

ACYLATION; BINDING SITE; CRYSTAL STRUCTURE; DRUG DESIGN; HYDROLYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR BIOLOGY; NONHUMAN; NOTE; PENICILLIN RESISTANCE; PRIORITY JOURNAL;

EID: 0037426051     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12719-5     Document Type: Note

References (13)

1. Wu S.W., de Lencastre H., Tomasz A. Recruitment of the mecA homologue of Staphylococcus sciuri into a resistance determinant and expression of the resistant phenotype in Staphylococcus aureus. J Bacteriol. 183:2001;2417-2424.
2. Ito T., Katayama Y., Asada K., et al. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 45:2001;1323-1336.
3. Crisóstomo M., Westh H., Tomasz A., Chung M., Oliveira D., de Lencastre H. The evolution of methicillin resistance in Staphylococcus aureus: Similarity of genetic backgrounds in historically early methicillin susceptible and resistant isolates and contemporary epidemic clones. Proc Natl Acad Sci USA. 98:2001;9865-9870.
4. Oliveira D.C., Tomasz A., de Lencastre H. The secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect Dis. 2:2002;181-190.
5. Enright M.C., Robinson D.A., Randle G., Feil E. J., Grundmann H., Spratt B.G. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA. 99:2002;7687-7692.
6. Lim D., Strynadka A. Structural basis for the β-lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Nat Struct Biol. 9:2002;870-876.
7. Toney J.H., Hammond G.G., Leiting B., et al. Soluble penicillin-binding protein 2a: β-lactam binding and inhibition by non-β-lactams using a 96-well format. Anal Biochem. 255:1998;113-119.
8. Pinho M.G., de Lencastre H., Tomasz A. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci. Proc Natl Acad Sci USA. 98:2001;10886-10891.
9. Dufour P., Gillet Y., Bes M., et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 35:2002;819-824.
10. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., Tenover F.C. Methicillin resistant Staphylococcus aureus clinical strains with reduced vancomycin susceptibility. J Antimicrob Chemother. 40:1997;135-136.
11. Sieradzki K., Roberts R.B., Haber S.W., Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med. 340:1999;517-523.
12. Public Health Dispatch. Vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002, MMWR Morb Mortal Wkly Rep 2002; 51: 902-03.
13. CDC. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 565-67.